Articles producció científica> Medicina i Cirurgia

The effects of fatty acid-based dietary interventions on circulating bioactive lipid levels as intermediate biomarkers of health, cardiovascular disease, and cardiovascular disease risk factors: a systematic review and meta-analysis of randomized cli

  • Datos identificativos

    Identificador: imarina:9287577
    Autores:
    Calderon-Perez, LCompanys, JSola, RPedret, AValls, RM
    Resumen:
    Dietary fatty acids (FAs), primarily n-3 polyunsaturated FAs, have been associated with enrichment of the circulating bioactive lipidome and changes in the enzymatic precursor lipoprotein-associated phospholipase A2 (Lp-PLA2) mass; however, the magnitude of this effect remains unclear.The aim of this systematic review and meta-analysis was to evaluate the effect of different dietary FAs on the bioactive lipid profile of healthy participants and those with cardiovascular disease (CVD) and CVD risk factors.PubMed, SCOPUS and the Cochrane Library databases were searched for relevant articles published between October 2010 and May 2022.Data were screened for relevance and then retrieved in full and evaluated for eligibility by 2 reviewers independently.The net difference in the bioactive lipid mean values between the endpoint and the baseline, and the corresponding SDs or SEs, were used for the qualitative synthesis. For the meta-analysis, a fixed-effects model was used.Twenty-seven randomized clinical trials (representing >2560 participants) were included. Over 78% of the enrolled participants had ≥1 associated CVD risk factor, whereas <22% were healthy. In the meta-analysis, marine n-3 supplements (dose range, 0.37-1.9 g/d) significantly increased pro-inflammatory lysophosphatidylcholines (lyso-PCs; for lyso-PC(16:0): mean, +0.52 [95% confidence interval (CI), 0.02-1.01] µM; for lyso-PC(18:0): mean, +0.58 [95%CI, 0.09-1.08] µM) in obese participants. Additionally, n-3 supplementation (1-5.56 g/d) decreased plasma Lp-PLA2 mass, a well-known inflammation marker, in healthy (-0.35 [95%CI, -0.59 to -0.10] ng/mL), dyslipidemic (-0.36 [95%CI, -0.47 to -0.25] ng/mL), and stable coronary artery disease participants (-0.52 [95%CI, -0.91 to -0.12] ng/mL).Daily n-3 provided as EPA+D
  • Otros:

    Autor según el artículo: Calderon-Perez, L; Companys, J; Sola, R; Pedret, A; Valls, RM
    Departamento: Medicina i Cirurgia
    Autor/es de la URV: Calderon Pérez, Lorena / Companys Alemany, Judit / Pedret Figuerola, Anna / Solà Alberich, Rosa Maria / Valls Zamora, Rosa Maria
    Palabras clave: Sphingolipids Polyunsaturated fatty acids Lysoglycerophospholipids Lipoprotein-associated phospholipase-a2 Lipoprotein-associated phospholipase a2 Glycerophospholipids Cardiovascular disease sphingolipids profile polyunsaturated fatty acids plasma omega-3-fatty-acids obesity lysoglycerophospholipids lipoprotein-associated phospholipase a2 inflammation glycerophospholipids global burden
    Resumen: Dietary fatty acids (FAs), primarily n-3 polyunsaturated FAs, have been associated with enrichment of the circulating bioactive lipidome and changes in the enzymatic precursor lipoprotein-associated phospholipase A2 (Lp-PLA2) mass; however, the magnitude of this effect remains unclear.The aim of this systematic review and meta-analysis was to evaluate the effect of different dietary FAs on the bioactive lipid profile of healthy participants and those with cardiovascular disease (CVD) and CVD risk factors.PubMed, SCOPUS and the Cochrane Library databases were searched for relevant articles published between October 2010 and May 2022.Data were screened for relevance and then retrieved in full and evaluated for eligibility by 2 reviewers independently.The net difference in the bioactive lipid mean values between the endpoint and the baseline, and the corresponding SDs or SEs, were used for the qualitative synthesis. For the meta-analysis, a fixed-effects model was used.Twenty-seven randomized clinical trials (representing >2560 participants) were included. Over 78% of the enrolled participants had ≥1 associated CVD risk factor, whereas <22% were healthy. In the meta-analysis, marine n-3 supplements (dose range, 0.37-1.9 g/d) significantly increased pro-inflammatory lysophosphatidylcholines (lyso-PCs; for lyso-PC(16:0): mean, +0.52 [95% confidence interval (CI), 0.02-1.01] µM; for lyso-PC(18:0): mean, +0.58 [95%CI, 0.09-1.08] µM) in obese participants. Additionally, n-3 supplementation (1-5.56 g/d) decreased plasma Lp-PLA2 mass, a well-known inflammation marker, in healthy (-0.35 [95%CI, -0.59 to -0.10] ng/mL), dyslipidemic (-0.36 [95%CI, -0.47 to -0.25] ng/mL), and stable coronary artery disease participants (-0.52 [95%CI, -0.91 to -0.12] ng/mL).Daily n-3 provided as EPA+DHA supplements and consumed from 1 to 6 months reduced plasma Lp-PLA2 mass in healthy participants and those with CVD and CVD risk factors, suggesting an anti-inflammatory effect. However, the saturated lyso-PC response to n-3 was impaired in obese participants.PROSPERO registration no. CRD42021218335.© The Author(s) 2022. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
    Áreas temáticas: Saúde coletiva Nutrition and dietetics Nutrition & dietetics Nutrição Medicine (miscellaneous) Medicine (all) Medicina iii Medicina ii Medicina i Interdisciplinar General medicine Enfermagem Educação física Ciências biológicas iii Ciências biológicas ii Biotecnología
    Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
    Direcció de correo del autor: lorena.calderon@urv.cat judit.companys@urv.cat anna.pedret@urv.cat judit.companys@urv.cat judit.companys@urv.cat lorena.calderon@urv.cat rosamaria.valls@urv.cat rosa.sola@urv.cat
    Identificador del autor: 0000-0003-0766-0733 0000-0003-1485-0818 0000-0002-5327-932X 0000-0003-1485-0818 0000-0003-1485-0818 0000-0003-0766-0733 0000-0002-3351-0942 0000-0002-8359-235X
    Fecha de alta del registro: 2024-08-03
    Versión del articulo depositado: info:eu-repo/semantics/acceptedVersion
    Enlace a la fuente original: https://academic.oup.com/nutritionreviews/advance-article-abstract/doi/10.1093/nutrit/nuac101/6955615?redirectedFrom=fulltext&login=false
    URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referencia al articulo segun fuente origial: Nutrition Reviews. 81 (8): 988-1033
    Referencia de l'ítem segons les normes APA: Calderon-Perez, L; Companys, J; Sola, R; Pedret, A; Valls, RM (2023). The effects of fatty acid-based dietary interventions on circulating bioactive lipid levels as intermediate biomarkers of health, cardiovascular disease, and cardiovascular disease risk factors: a systematic review and meta-analysis of randomized clinical trials. Nutrition Reviews, 81(8), 988-1033. DOI: 10.1093/nutrit/nuac101
    DOI del artículo: 10.1093/nutrit/nuac101
    Entidad: Universitat Rovira i Virgili
    Año de publicación de la revista: 2023
    Tipo de publicación: Journal Publications
  • Palabras clave:

    Medicine (Miscellaneous),Nutrition & Dietetics,Nutrition and Dietetics
    Sphingolipids
    Polyunsaturated fatty acids
    Lysoglycerophospholipids
    Lipoprotein-associated phospholipase-a2
    Lipoprotein-associated phospholipase a2
    Glycerophospholipids
    Cardiovascular disease
    sphingolipids
    profile
    polyunsaturated fatty acids
    plasma
    omega-3-fatty-acids
    obesity
    lysoglycerophospholipids
    lipoprotein-associated phospholipase a2
    inflammation
    glycerophospholipids
    global burden
    Saúde coletiva
    Nutrition and dietetics
    Nutrition & dietetics
    Nutrição
    Medicine (miscellaneous)
    Medicine (all)
    Medicina iii
    Medicina ii
    Medicina i
    Interdisciplinar
    General medicine
    Enfermagem
    Educação física
    Ciências biológicas iii
    Ciências biológicas ii
    Biotecnología
  • Documentos:

  • Cerca a google

    Search to google scholar